FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

922616011000036107: cyanocobalamin 1 mg / 2.5 mL + dexpanthenol 50 mg / 2.5 mL + nicotinamide 50 mg / 2.5 mL + pyridoxine hydrochloride 100 mg / 2.5 mL + riboflavin sodium phosphate 5 mg / 2.5 mL + thiamine hydrochloride 250 mg / 2.5 mL injection, 3 x 2.5 mL vials (medicinal product pack)

  • Australian concept\Australian product\medicinal product pack\thiamine hydrochloride 250 mg/2.5 mL + riboflavin sodium phosphate 5 mg/2.5 mL + nicotinamide 50 mg/2.5 mL + dexpanthenol 50 mg/2.5 mL + pyridoxine hydrochloride 100 mg/2.5 mL + cyanocobalamin 1 mg/2.5 mL injection, 3 x 2.5 mL vials

Status: current, Defined. Date: 31-Oct 2010. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
940288011000036118 thiamine hydrochloride 250 mg/2.5 mL + riboflavin sodium phosphate 5 mg/2.5 mL + nicotinamide 50 mg/2.5 mL + dexpanthenol 50 mg/2.5 mL + pyridoxine hydrochloride 100 mg/2.5 mL + cyanocobalamin 1 mg/2.5 mL injection, 3 x 2.5 mL vials en Synonym Active Case sensitive Australian Medicines Terminology module
940289011000036114 cyanocobalamin 1 mg / 2.5 mL + dexpanthenol 50 mg / 2.5 mL + nicotinamide 50 mg / 2.5 mL + pyridoxine hydrochloride 100 mg / 2.5 mL + riboflavin sodium phosphate 5 mg / 2.5 mL + thiamine hydrochloride 250 mg / 2.5 mL injection, 3 x 2.5 mL vials (medicinal product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
thiamine hydrochloride 250 mg/2.5 mL + riboflavin sodium phosphate 5 mg/2.5 mL + nicotinamide 50 mg/2.5 mL + dexpanthenol 50 mg/2.5 mL + pyridoxine hydrochloride 100 mg/2.5 mL + cyanocobalamin 1 mg/2.5 mL injection, 3 x 2.5 mL vials Is a medicinal product pack true Inferred relationship Some
thiamine hydrochloride 250 mg/2.5 mL + riboflavin sodium phosphate 5 mg/2.5 mL + nicotinamide 50 mg/2.5 mL + dexpanthenol 50 mg/2.5 mL + pyridoxine hydrochloride 100 mg/2.5 mL + cyanocobalamin 1 mg/2.5 mL injection, 3 x 2.5 mL vials has MPUU thiamine hydrochloride 250 mg/2.5 mL + riboflavin sodium phosphate 5 mg/2.5 mL + nicotinamide 50 mg/2.5 mL + dexpanthenol 50 mg/2.5 mL + pyridoxine hydrochloride 100 mg/2.5 mL + cyanocobalamin 1 mg/2.5 mL injection, vial true Inferred relationship Some 1
Inbound Relationships Type Active Source Characteristic Refinability Group
B-Dose (Biological Therapies) injection: solution, 3 x 2.5 mL vials Is a False thiamine hydrochloride 250 mg/2.5 mL + riboflavin sodium phosphate 5 mg/2.5 mL + nicotinamide 50 mg/2.5 mL + dexpanthenol 50 mg/2.5 mL + pyridoxine hydrochloride 100 mg/2.5 mL + cyanocobalamin 1 mg/2.5 mL injection, 3 x 2.5 mL vials Inferred relationship Some
B-Dose Forte (Biological Therapies) injection, 3 x 2.5 mL vials Is a True thiamine hydrochloride 250 mg/2.5 mL + riboflavin sodium phosphate 5 mg/2.5 mL + nicotinamide 50 mg/2.5 mL + dexpanthenol 50 mg/2.5 mL + pyridoxine hydrochloride 100 mg/2.5 mL + cyanocobalamin 1 mg/2.5 mL injection, 3 x 2.5 mL vials Inferred relationship Some

Reference Sets

List of Excluded Medicinal Items reference set

Medicinal product pack reference set

Back to Start